Skip to main content

Table 1 Risk Ratio and Hazard Ratio for survival on the basis of ALT status

From: Alternative lengthening of telomeres (ALT) influences survival in soft tissue sarcomas: a systematic review with meta-analysis

Parameter N Cohorts Risk Ratio (95% CI) p Value Heterogeneity (I2%); tau2 Egger Test (p value)
Survival 8 1.50 (1.15–1.96) 0.003 53%; 0.07 1.49 (0.17)
Parameter N Cohorts Hazard Ratio (95% CI) p Value Heterogeneity (I2); tau2 Egger Test (p value)
Survival 6 2.02 (1.22–3.38) 0.007 49.8%; 0.19 1.40 (0.57)